Alphatec Spine Announces Retirement of James R. Glynn From Its Board of Directors; Donald A. Williams Appointed Audit Committ...
October 30 2015 - 9:05AM
Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of
Alphatec Spine, Inc., a global provider of spinal fusion
technologies, announced today that James R. Glynn is retiring as a
member of the board of directors and Audit Committee Chairman,
effective November 2, 2015. Alphatec Spine’s board of
directors has appointed Donald A. Williams, an independent director
of Alphatec’s board of directors and current member of the Audit
Committee, as the Chairman of the Audit Committee, effective
November 2, 2015.
Mr. Williams joined the board of directors in
May 2015 and previously was a Partner at Ernst & Young for
eighteen years and a Partner with Grant Thornton, LLP for the last
seven years. He has served as the lead partner on multiple initial
public offerings, secondary offerings, private and public debt
financings, as well as numerous mergers and acquisitions.
“We would like to thank Jim for his dedicated
service and many contributions to Alphatec over the past eight
years,” said Jim Corbett, President and Chief Executive Officer of
Alphatec Spine. “We appreciate his counsel and leadership
during his tenure and wish him all the best in the future.
Looking forward, we are very pleased to have Don serve as Chairman
of the Audit Committee. Don’s deep financial experience and
strong business acumen has been a valuable asset to the board this
year. We look forward to Don’s guidance and operational
expertise in his newly expanded role as we continue to execute the
pillars of our strategy and build momentum for the future.”
Further information regarding the Company’s appointment of
Donald A. Williams to its board of directors is set forth in a
Current Reports on Form 8-K that the Company is expecting to file
with the U.S. Securities and Exchange Commission (SEC) on November
2, 2015 and will be available on both the SEC’s website at
www.sec.gov and the Company’s website at www.alphatecspine.com.
About Alphatec Spine
Alphatec Spine, Inc., a wholly owned subsidiary
of Alphatec Holdings, Inc., is a global medical device company that
designs, develops, manufactures and markets spinal fusion
technology products and solutions for the treatment of spinal
disorders associated with disease and degeneration, congenital
deformities and trauma. The Company's mission is to improve lives
by delivering advancements in spinal fusion technologies. The
Company and its affiliates market products in the U.S. and
internationally via a direct sales force and independent
distributors.
Additional information can be found at
www.alphatecspine.com.
Forward Looking Statements
This press release may contain "forward-looking statements"
within the meaning of the Private Securities Litigation Reform Act
of 1995 that involve risks and uncertainty. Such statements are
based on management's current expectations and are subject to a
number of risks and uncertainties that could cause actual results
to differ materially from those described in the forward-looking
statements. Alphatec Spine cautions investors that there can be no
assurance that actual results or business conditions will not
differ materially from those projected or suggested in such
forward-looking statements as a result of various factors.
Forward-looking statements include the Company's ability to execute
on its strategy to build momentum in the future; achieve profitable
growth; the Company’s ability to achieve both domestic and
international growth and future profitability. The words
"believe," "will," "should," "expect," "intend," "estimate" and
"anticipate," variations of such words and similar expressions
identify forward-looking statements, but their absence does not
mean that a statement is not a forward-looking statement.
Please refer to the risks detailed from time to time in Alphatec
Spine's SEC reports, including its Annual Report Form 10-K, as well
as other filings on Form 10-Q and periodic filings on Form
8-K. Alphatec Spine disclaims any intention or obligation to
update or revise any forward-looking statements, whether as a
result of new information, future events, or otherwise, unless
required by law.
CONTACT: Investor/Media Contact:
Christine Zedelmayer
Investor Relations
Alphatec Spine, Inc.
(760) 494-6610
czedelmayer@alphatecspine.com
Alphatec (NASDAQ:ATEC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alphatec (NASDAQ:ATEC)
Historical Stock Chart
From Apr 2023 to Apr 2024